Similarly, LNA-anti-miR-192 ameliorated DN in C57 type 1 diabetic mice by restoring the function of ECM inhibitor ZEB1/2, leading to downregulation of ECM genes and less albuminuria [26]. The gene discussed is ZEB1; the disease is liver dysplastic nodule.